Introducing Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) – the powerful tool in the fight against tuberculosis.
This highly specific and potent antibody targets the icl1/Isocitrate lyase 1 protein found in Mycobacterium tuberculosis, the bacteria responsible for causing tuberculosis. By binding to this protein, Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) effectively inhibits its activity, making it an essential tool for researchers studying this deadly disease.
The biological function of icl1/Isocitrate lyase 1 in Mycobacterium tuberculosis is crucial for the bacteria’s survival and replication. This enzyme plays a key role in the glyoxylate cycle, a metabolic pathway that allows the bacteria to use fatty acids as a source of energy. By targeting icl1/Isocitrate lyase 1, this antibody disrupts the bacteria’s ability to produce energy, ultimately leading to its death.
The main application of Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) is in tuberculosis research. It is an essential tool for studying the role of icl1/Isocitrate lyase 1 in the pathogenesis of tuberculosis and its potential as a drug target. This antibody is also useful in the development and testing of new treatments for tuberculosis.
Experimental use cases of Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) include Western blotting, immunoprecipitation, and immunofluorescence. It has been validated for use in both human and animal samples, making it a versatile tool for research in both clinical and preclinical settings.
With its high specificity and potency, Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) is a valuable addition to any tuberculosis research project. Don’t settle for generic explanations – choose Anti-Mycobacterium tuberculosis icl1/Isocitrate lyase 1 Antibody (SAA2568) for your tuberculosis research needs.
There are no reviews yet.